Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.60 0.11% 1,405.20 1,403.80 1,404.40 1,416.00 1,400.00 1,404.60 11,824,382 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 34,114.0 5,442.0 87.6 16.0 57,154

Gsk Share Discussion Threads

Showing 31176 to 31198 of 31675 messages
Chat Pages: Latest  1255  1254  1253  1252  1251  1250  1249  1248  1247  1246  1245  1244  Older
DateSubjectAuthorDiscuss
06/10/2022
19:28
The guy is a penniless dolt-spends his jobless days on ADVFN trolling various boards. Filtered the loser ages ago.
cumnor
06/10/2022
18:39
Jeepers TM nobody knows the full extent of the Zantac litigation and which companies will get hit with legal costs. As for cashflow 9 billion shares 1.8p or 3.6p assuming 100% payout, 50% payout yield just 1.8p per share that is terrible!!!
paul planet earth
06/10/2022
10:10
PPE is just a troll and not worth the effort indulging..
rikky72
06/10/2022
09:22
GSK dividends in my accounts this morning (thx to AJ Bell)
tradermichael
06/10/2022
07:56
PPE, I think you are overreacting. Haleon has said it had rejected indemnification requests from GSK and Pfizer “on the basis that the scope of the indemnities set out in the joint venture agreement only covers their consumer healthcare businesses as conducted when the JV was formed in 2018”.

It added: “At that time, neither GSK nor Pfizer marketed [over the counter] Zantac in the US or Canada.”

Litigation surrounding Zantac, which was previously marketed by GSK and Pfizer is a distraction, but Haleon itself never marketed this product and significant financial costs are not anticipated, other than those of defending the litigation, being incurred by Haleon as a result.

And on cash flow, the group expects continued growth in the second half of the year, albeit not at such a strong pace. Cash flow was especially strong, with the group delivering free cash flow of over £550m in the half-year, compared to £364m at the 2021 half-year stage.
With strong cash flows, Haleon should rapidly deleverage, which will help to drive financial returns higher, over and above the growth from the brands portfolio. Haleon should have excellent dividend growth potential over the longer term as a result.

tradermichael
06/10/2022
07:21
Doubt it GSK and Pfizer will start dumping come November afterall you've got a multi billion dollar Zantac law suite to fund. Why hold Haleon shares that generate f@@kall cash flow!
paul planet earth
06/10/2022
07:01
Feel free to dump your shares Paul , wiser to keep them though
alibizzle
06/10/2022
06:48
Haleon H2 results EPS 9p a share so 3p to 4.5p dividend payout to GSK investors..better dumping those shares at 270p not even a 2% share holder yield!..Most of their free cash flow used up servicing £8 billion debt ffs and that's at just 2.8% f@@k knows how they will cope as interest rates rise and find debt reduction is harder to achieve, higher inflation, rising cost base, consumers cutting spending and switching to generic cheaper rivals brands!
paul planet earth
06/10/2022
06:31
PPE: In its H1 earnings report, Haleon expected the initial dividend to be at the lower end of a 30%-50% pay-out ratio, subject to board approval.
tradermichael
05/10/2022
07:53
Glaxo Wellcome (GW) and SmithKline Beecham (SB) joined forces at the end of 2000. The £114 billion merger created a giant with an estimated global market share of 7% of the world pharmaceutical market.

In over 20 years since then, how much has the company added value to the business?

tradermichael
04/10/2022
18:20
Thats alot of shares to dump especially as Halitosis told both Pfizer and GSK to get stuffed regarding the Zantac indemnities.
paul planet earth
04/10/2022
08:07
Still a lot of dust in the air until after the options to sell in November following the 'lock-up' period ....
(Pfizer, 32%, GSK 6%)

tradermichael
04/10/2022
07:38
Any views on the Halitosis IPO sell off..was it a good or bad move by the GSK board in light of Unlevers original offer now the dust has settled?
paul planet earth
03/10/2022
07:48
Stopped updating price on GSK website
jonjoneil
03/10/2022
07:02
....and there's sub 13!
spoole5
01/10/2022
12:29
Thanks Michael .
alibizzle
01/10/2022
07:09
“Haleon expects to pay a dividend to Haleon shareholders in relation to the second half of 2022 in the first half of 2023, subject to Haleon Board approval and following approval of Haleon's FY22 results.”
tradermichael
30/9/2022
18:52
When does haleon divided pay out ?
alibizzle
30/9/2022
14:54
16.25p dividend pays out next Thursday .... ;0)
tradermichael
29/9/2022
15:01
Porsche is just a sad troll . Yawn
alibizzle
29/9/2022
14:15
Porsche1945. Filtered
tday
29/9/2022
11:28
Looks like the brexit loony Tory basket cases that ubs just described as akin to a death wish cult, have finally managed to blow up the U.K. once and for all. Gsk of course with another load of problems on top all of its own.
porsche1945
29/9/2022
08:45
1815p last April, 1815p next April!
tradermichael
Chat Pages: Latest  1255  1254  1253  1252  1251  1250  1249  1248  1247  1246  1245  1244  Older
Your Recent History
LSE
GSK
Gsk
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 05:23:42